What does KS Pharma do?

KS Pharma is filed with the CBE under the catch-all “Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten”, a code that says little about what the company actually does. Private Limited, started on 4 December 2019, 2 establishments.

What is the address of KS Pharma?

The registered office of KS Pharma is located at Terlicht(HE) 251, 9450 Haaltert.

Is KS Pharma still active?

No. The CBE lists KS Pharma with legal situation “Opening faillissement”. The date of the court ruling is published in the Belgian Official Gazette; the register does not carry it.

Is KS Pharma registered on Peppol?

Yes, KS Pharma is registered on the Peppol network with ID 0208:0738746258.

What is the enterprise number of KS Pharma?

The enterprise number of KS Pharma is BE0738746258.

When was KS Pharma founded?

KS Pharma was founded on 4 December 2019.

Who are the directors of KS Pharma?

According to the 2024 annual accounts, the directors of KS Pharma are: SACHA MASSON, KCHC.

Is KS Pharma a reliable company?

Databakkes does not pass judgement; this is what the sources say: Opening faillissement according to the CBE, started on 4 December 2019; 4 annual accounts filed, latest fiscal year 2024; 2 directors known from the annual account; 2 establishments in the CBE.

How much profit did KS Pharma make in 2024?

KS Pharma posted a profit after taxes of € 334 in financial year 2024.

What is the revenue of KS Pharma?

As a small company, KS Pharma is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 120,481.

Does KS Pharma have a website?

Yes, KS Pharma has a website at kspharma.eu.

KS Pharma (Private Limited) - Haaltert - BE0738746258

Dossier KS Pharma, printed on 30 October 2026 from databakkes.be/en/0738746258/ks-pharma. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Legal situation KBO

Opening faillissement according to the CBE.

Financials

Financial year 2024

KS Pharma from Haaltert, company number BE0738746258, closed financial year 2024 with a result of € 334 after tax. For that financial year KS Pharma recorded a gross margin of € 120,481 and equity of € 6,025. Compared with financial year 2023, the result moved from € 898 to € 334. The company is profitable. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 31, 2025.

What it is worth Growing

€ 6,025

▲ 6% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 334

▼ 63% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 42,882

▲ 83% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2024. Retained profit grew to € 3,525.

People and assets in 2024

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Wage cost

€ 113,678

▲ 160% vs 2023

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2024

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 38,837

€ 8,837 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 197,207

▲ 15% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 7,178

▼ 33% vs 2023

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 2,145 Gross margin 2021: € 2,145 First fiscal year in the series	€ 1,321 Gross margin 2022: € 1,321 ▼ 38% vs 2021 (€ 2,145) Unfavourable step	€ 51,055 Gross margin 2023: € 51,055 ▲ € 49,733 vs 2022 (€ 1,321) Favourable step	€ 120,481 Gross margin 2024: € 120,481 ▲ 136% vs 2023 (€ 51,055) Favourable step	▲ 136%
Profit after taxes	€ 856 Profit after taxes 2021: € 856 First fiscal year in the series	€ 359 Profit after taxes 2022: € 359 ▼ 58% vs 2021 (€ 856) Unfavourable step	€ 898 Profit after taxes 2023: € 898 ▲ 150% vs 2022 (€ 359) Favourable step	€ 334 Profit after taxes 2024: € 334 ▼ 63% vs 2023 (€ 898) Unfavourable step	▼ 63%
Equity	€ 4,435 Equity 2021: € 4,435 First fiscal year in the series	€ 4,794 Equity 2022: € 4,794 ▲ 8% vs 2021 (€ 4,435) Favourable step	€ 5,692 Equity 2023: € 5,692 ▲ 19% vs 2022 (€ 4,794) Favourable step	€ 6,025 Equity 2024: € 6,025 ▲ 6% vs 2023 (€ 5,692) Favourable step	▲ 6%
Total debts	€ 86,386 Total debts 2021: € 86,386 First fiscal year in the series	€ 162,385 Total debts 2022: € 162,385 ▲ 88% vs 2021 (€ 86,386) Unfavourable step	€ 181,666 Total debts 2023: € 181,666 ▲ 12% vs 2022 (€ 162,385) Unfavourable step	€ 243,735 Total debts 2024: € 243,735 ▲ 34% vs 2023 (€ 181,666) Unfavourable step	▲ 34%
Cash	€ 5,659 Cash 2021: € 5,659 First fiscal year in the series	€ 17,127 Cash 2022: € 17,127 ▲ 203% vs 2021 (€ 5,659) Favourable step	€ 23,401 Cash 2023: € 23,401 ▲ 37% vs 2022 (€ 17,127) Favourable step	€ 42,882 Cash 2024: € 42,882 ▲ 83% vs 2023 (€ 23,401) Favourable step	▲ 83%
Retained profit	€ 1,935 Retained profit 2021: € 1,935 First fiscal year in the series	€ 2,294 Retained profit 2022: € 2,294 ▲ 19% vs 2021 (€ 1,935) Favourable step	€ 3,192 Retained profit 2023: € 3,192 ▲ 39% vs 2022 (€ 2,294) Favourable step	€ 3,525 Retained profit 2024: € 3,525 ▲ 10% vs 2023 (€ 3,192) Favourable step	▲ 10%
Bank debt	€ 0 Bank debt 2021: € 0 First fiscal year in the series	€ 0 Bank debt 2022: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 38,837 Bank debt 2024: € 38,837 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 90,821 Balance sheet total 2021: € 90,821 First fiscal year in the series	€ 167,179 Balance sheet total 2022: € 167,179 ▲ 84% vs 2021 (€ 90,821) Unchanged	€ 187,358 Balance sheet total 2023: € 187,358 ▲ 12% vs 2022 (€ 167,179) Unchanged	€ 249,761 Balance sheet total 2024: € 249,761 ▲ 33% vs 2023 (€ 187,358) Unchanged	▲ 33%

Key figures of KS Pharma, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to KS Pharma?

What happened at KS Pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

KS Pharma is active according to the CBE. Legal situation: Opening faillissement.

Jul 31, 2025 New annual accounts for financial year 2024: profit of € 334 (▼ 63% vs 2023). Source: NBB ↗
Jul 2, 2025 New establishment in Schaarbeek. KBO
2022 SACHA MASSON became a director. NBB
Dec 4, 2019 New establishment in Haaltert. KBO
2019 KCHC became a director. NBB
Dec 4, 2019 Start of the company according to the CBE. KBO

In short

From € 856 profit in 2021 to € 334 profit in 2024.

Paid € 957 in corporate taxes since 2021.

Best year ever: 2023, with € 898 profit.

Original PDFs at the National Bank ↗

Management

SACHA MASSON KCHC

KS Pharma

Behind KS Pharma are SACHA MASSON and KCHC.

Directors

According to the 2024 annual accounts

SACHA MASSON

Director

since 2022

KCHC

Director · represented by KATRIEN COPPENS

since 2019

Establishments

Establishment units

Physical locations of this company

Registered office

Terlicht(HE) 251

9450 Haaltert

2.375.341.740

Eugène Plaskysquare 105 box 1

1030 Schaarbeek

Active since 2 July 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS kspharma.eu

Canonical: https://www.kspharma.eu

Technologies

Advanced Custom FieldsGoogle AnalyticsLodashPWAReactWixlazysizes

Hosting & Email

Email provider

Microsoft 365

Hosting

WIX_COM, IL

Domain

kspharma.eu

Registrar

Combell NV

Website info

HTTPS Ja

Languages FR

Features

Webshop

Security

✓ HTTPS

✓ SPF

✓ DMARC

Details

Company number

0738.746.258

VAT number

BE 0738.746.258

Registered office

Terlicht(HE) 251, 9450 Haaltert

Names & denominations

KS Pharma

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Opening faillissement

Start date

4 December 2019

Peppol

Active · Active since 31 Oct 2023

Contact

kspharma.eu +32 53 39 01 01

Activities · NACE

Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg

Overige gespecialiseerde wetenschappelijke en technische activiteiten

Overige zakelijke dienstverlening, neg

View on CBE Public ↗ Annual accounts (NBB) ↗

KS Pharma

Warning lights

Financials

What happened to KS Pharma?

Management

Directors

Establishments

Establishment units

Website

Technologies

Hosting & Email

Domain

Website info

Features

Security

Details

Frequently asked questions